Chemotherapeutic fluoroquinolone toxicity fluoroquinolones. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Tumor Cells, Cultured Feces Cell Line

Organisms40

Streptococcus pneumoniae Escherichia coli Staphylococcus aureus Gram-Negative Bacteria Gram-Positive Bacteria Mycoplasma hominis Pseudomonas aeruginosa Mycobacterium tuberculosis Clostridium difficile Neisseria gonorrhoeae Salmonella typhi Salmonella enterica Mycobacterium fortuitum Bacteria, Anaerobic Bacteria Klebsiella pneumoniae Salmonella paratyphi A Campylobacter jejuni Campylobacter Enterobacteriaceae Gram-Positive Cocci Campylobacter coli Moraxella (Branhamella) catarrhalis Mycobacterium smegmatis Bacteroides fragilis Enterococcus faecalis Acinetobacter Haemophilus influenzae Laurus Bartonella bacilliformis Salmonella Mice, Nude Methicillin-Resistant Staphylococcus aureus Staphylococcus Streptococcus pyogenes Mycobacterium Mice, Inbred BALB C Serratia marcescens Salmonella typhimurium Ureaplasma

Diseases39

Dermatitis, Phototoxic Gram-Negative Bacterial Infections Escherichia coli Infections Bacterial Infections Pneumococcal Infections Urinary Tract Infections Community-Acquired Infections Typhoid Fever Eye Infections, Bacterial Tuberculosis, Multidrug-Resistant Dermatitis, Photoallergic Gonorrhea Cross Infection Paratyphoid Fever Pseudomonas Infections Campylobacter Infections Respiratory Tract Infections Gram-Positive Bacterial Infections Enterocolitis, Pseudomembranous Salmonella Infections Bacteremia Staphylococcal Infections Neoplasms Extensively Drug-Resistant Tuberculosis Klebsiella Infections Pneumonia, Bacterial Tuberculosis Bronchitis, Chronic Neutropenia Pneumonia, Pneumococcal Enterobacteriaceae Infections Streptococcal Infections Diarrhea Otitis Externa Lung Neoplasms Breast Neoplasms Poultry Diseases Clostridium Infections Corneal Ulcer

Chemicals and Drugs77

Fluoroquinolones Anti-Infective Agents DNA Gyrase Ciprofloxacin Ofloxacin DNA Topoisomerase IV Aza Compounds Levofloxacin Quinolones Anti-Bacterial Agents Norfloxacin Naphthyridines Pefloxacin Quinolines DNA Topoisomerases, Type II Enoxacin 4-Quinolones Nalidixic Acid Topoisomerase II Inhibitors Antineoplastic Agents DNA, Bacterial Fleroxacin Antitubercular Agents Macrolides Bacterial Proteins Doxorubicin beta-Lactams DNA Topoisomerases Aminoglycosides Cisplatin Anti-Infective Agents, Urinary Dioxolanes Multidrug Resistance-Associated Proteins Cephalosporins Membrane Transport Proteins beta-Lactamases Antineoplastic Agents, Phytogenic Paclitaxel Erythromycin Piperazines Antibiotics, Antineoplastic Reserpine Fluorouracil Nitrofurantoin Trimethoprim-Sulfamethoxazole Combination Ethambutol Lactams Capreomycin Etoposide Streptogramin B Antimetabolites, Antineoplastic Antineoplastic Agents, Alkylating Rifampin Carbapenems Ethidium Culture Media Deoxycytidine Ceftriaxone Escherichia coli Proteins Camptothecin Enzyme Inhibitors Cyclophosphamide Vincristine Azithromycin Bacterial Outer Membrane Proteins Penicillins Chloramphenicol Doxycycline P-Glycoprotein Vinblastine Tetracyclines Ampicillin Dacarbazine Methotrexate ATP-Binding Cassette Transporters Taxoids DNA, Superhelical

Analytical, Diagnostic and Therapeutic Techniques and Equipment34

Microbial Sensitivity Tests Toxicity Tests Area Under Curve Administration, Oral Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Toxicity Tests, Acute Electrophoresis, Gel, Pulsed-Field Sequence Analysis, DNA Polymerase Chain Reaction Amino Acid Substitution Colony Count, Microbial Drug Therapy, Combination Reverse Transcriptase Polymerase Chain Reaction Drug Administration Schedule Ribotyping Disk Diffusion Antimicrobial Tests Drug Screening Assays, Antitumor Antibiotic Prophylaxis Retrospective Studies Treatment Failure Culture Media Molecular Typing Lethal Dose 50 Xenograft Model Antitumor Assays Models, Biological Combined Modality Therapy Bacterial Typing Techniques Chromatography, High Pressure Liquid Chromatography, Supercritical Fluid Serum Bactericidal Test Serotyping Inhibitory Concentration 50 Risk Factors

Phenomena and Processes35

Drug Resistance, Bacterial Drug Resistance, Microbial Drug Resistance, Multiple, Bacterial Mutation Drug Resistance, Multiple Dose-Response Relationship, Drug Drug Resistance, Neoplasm Area Under Curve Apoptosis Drug Interactions Genes, Bacterial Cell Survival Drug Synergism Time Factors Amino Acid Substitution beta-Lactam Resistance Methicillin Resistance Plasmids Cephalosporin Resistance Point Mutation Structure-Activity Relationship Genotype Mutation, Missense Phenotype Penicillin Resistance Base Sequence Lethal Dose 50 Molecular Structure Amino Acid Sequence Cell Proliferation Genes, MDR DNA Damage Inhibitory Concentration 50 Microbial Viability DNA, Superhelical

Information Science4

Molecular Sequence Data Formularies, Hospital Base Sequence Amino Acid Sequence

Named Groups1

Health Care8

Drug Utilization Area Under Curve Treatment Outcome Hospitals Retrospective Studies Treatment Failure Hospitals, County Risk Factors

Geographicals3

United States Taiwan France

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care Geographicals

Fluoroquinolones Anti-Infective Agents DNA Gyrase Ciprofloxacin Ofloxacin DNA Topoisomerase IV Aza Compounds Levofloxacin Microbial Sensitivity Tests Drug Resistance, Bacterial Quinolones Anti-Bacterial Agents Norfloxacin Naphthyridines Pefloxacin Quinolines Drug Resistance, Microbial DNA Topoisomerases, Type II Enoxacin 4-Quinolones Drug Resistance, Multiple, Bacterial Streptococcus pneumoniae Nalidixic Acid Dermatitis, Phototoxic Topoisomerase II Inhibitors Antineoplastic Agents Mutation Escherichia coli Drug Resistance, Multiple Staphylococcus aureus Gram-Negative Bacteria DNA, Bacterial Fleroxacin Antitubercular Agents Macrolides Gram-Positive Bacteria Gram-Negative Bacterial Infections Escherichia coli Infections Toxicity Tests Bacterial Infections Pneumococcal Infections Bacterial Proteins Drug Utilization Mycoplasma hominis Dose-Response Relationship, Drug Pseudomonas aeruginosa Doxorubicin beta-Lactams Mycobacterium tuberculosis DNA Topoisomerases Urinary Tract Infections Community-Acquired Infections Clostridium difficile Typhoid Fever Eye Infections, Bacterial Cell Line, Tumor Aminoglycosides Drug Resistance, Neoplasm Cisplatin Area Under Curve Neisseria gonorrhoeae Salmonella typhi Tuberculosis, Multidrug-Resistant Salmonella enterica Mycobacterium fortuitum Apoptosis Dermatitis, Photoallergic Bacteria, Anaerobic Bacteria Anti-Infective Agents, Urinary Klebsiella pneumoniae Gonorrhea Cross Infection Dioxolanes Drug Interactions Administration, Oral Genes, Bacterial Salmonella paratyphi A Cell Survival Multidrug Resistance-Associated Proteins Drug Synergism Paratyphoid Fever Campylobacter jejuni Cephalosporins Membrane Transport Proteins Pseudomonas Infections Antineoplastic Combined Chemotherapy Protocols Campylobacter Infections Treatment Outcome Toxicity Tests, Acute Respiratory Tract Infections beta-Lactamases Electrophoresis, Gel, Pulsed-Field Campylobacter Sequence Analysis, DNA Gram-Positive Bacterial Infections Time Factors Enterocolitis, Pseudomembranous Salmonella Infections Antineoplastic Agents, Phytogenic

No FAQ available that match "chemotherapeutic fluoroquinolone toxicity fluoroquinolones"